The aggregation of amyloid-β (Aβ) peptides
into senile
plaques is a hallmark of Alzheimer’s disease (AD) and is hypothesized
to be the primary cause of AD related neurodegeneration. Previous studies have shown the
ability of curcumin to both inhibit the aggregation of Aβ peptides
into oligomers or fibrils and reduce amyloids
in vivo
. Despite the promise of curcumin and its derivatives to serve as
diagnostic, preventative, and potentially therapeutic AD molecules,
the mechanism by which curcumin and its derivatives bind to and inhibit
Aβ fibrils’ formation remains elusive. Here, we investigated
curcumin and a set of curcumin derivatives in complex with a hexamer
peptide model of the Aβ
1–42
fibril using nearly
exhaustive docking, followed by multi-ns molecular dynamics simulations,
to provide atomistic-detail insights into the molecules’ binding
and inhibitory properties. In the vast majority of the simulations,
curcumin and its derivatives remain firmly bound in complex with the
fibril through primarily three different principle binding modes,
in which the molecules interact with residue domain
17
LVFFA
21
, in line with previous experiments. In a small subset of
these simulations, the molecules partly dissociate the outermost peptide
of the Aβ
1–42
fibril by disrupting β-sheets
within the residue domain
12
VHHQKLVFF
20
. A comparison
between binding modes leading or not leading to partial dissociation
of the outermost peptide suggests that the latter is attributed to
a few subtle key structural and energetic interaction-based differences.
Interestingly, partial dissociation appears to be either an outcome
of high affinity interactions or a cause leading to high affinity
interactions between the molecules and the fibril, which could partly
serve as a compensation for the energy loss in the fibril due to partial
dissociation. In conjunction with this, we suggest a potential inhibition
mechanism of Αβ
1–42
aggregation by the
molecules, where the partially dissociated
16
KLVFF
20
domain of the outermost peptide could either remain unstructured
or wrap around to form intramolecular interactions with the same peptide’s
29
GAIIG
33
domain, while the molecules could additionally
act as a patch against the external edge of the second outermost peptide’s
16
KLVFF
20
domain. Thereby, individually or concurrently,
these could prohibit fibril elongation.